Literature DB >> 9166930

Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization.

G Armengol1, M Tarkkanen, M Virolainen, A Forus, J Valle, T Böhling, S Asko-Seljavaara, C Blomqvist, I Elomaa, E Karaharju, A H Kivioja, M A Siimes, E Tukiainen, M R Caballín, O Myklebost, S Knuutila.   

Abstract

Comparative genomic hybridization (CGH) was used to detect copy number changes of DNA sequences in the Ewing family of tumours (ET). We analysed 20 samples from 17 patients. Fifteen tumours (75%) showed copy number changes. Gains of DNA sequences were much more frequent than losses, the majority of the gains affecting whole chromosomes or whole chromosome arms. Recurrent findings included copy number increases for chromosomes 8 (seven out of 20 samples; 35%), 1q (five samples; 25%) and 12 (five samples; 25%). The minimal common regions of these gains were the whole chromosomes 8 and 12, and 1q21-22. High-level amplifications affected 8q13-24, 1q and 1q21-22, each once. Southern blot analysis of the specimen with high-level amplification at 1q21-22 showed an amplification of FLG and SPRR3, both mapped to this region. All cases with a gain of chromosome 12 simultaneously showed a gain of chromosome 8. Comparison of CGH findings with cytogenetic analysis of the same tumours and previous cytogenetic reports of ET showed, in general, concordant results. In conclusion, our findings confirm that secondary changes, which may have prognostic significance in ET, are trisomy 8, trisomy 12 and a gain of DNA sequences in 1q.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9166930      PMCID: PMC2223493          DOI: 10.1038/bjc.1997.242

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

1.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours.

Authors:  O Delattre; J Zucman; B Plougastel; C Desmaze; T Melot; M Peter; H Kovar; I Joubert; P de Jong; G Rouleau
Journal:  Nature       Date:  1992-09-10       Impact factor: 49.962

2.  Complexity of 12q13-22 amplicon in liposarcoma: microsatellite repeat analysis.

Authors:  M Wolf; L A Aaltonen; J Szymanska; M Tarkkanen; C Blomqvist; J M Berner; O Myklebost; S Knuutila
Journal:  Genes Chromosomes Cancer       Date:  1997-01       Impact factor: 5.006

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12).

Authors:  C Turc-Carel; A Aurias; F Mugneret; S Lizard; I Sidaner; C Volk; J P Thiery; S Olschwang; I Philip; M P Berger
Journal:  Cancer Genet Cytogenet       Date:  1988-06

5.  Chromosomes in Ewing's sarcoma. II. Nonrandom additional changes, trisomy 8 and der(16)t(1;16).

Authors:  F Mugneret; S Lizard; A Aurias; C Turc-Carel
Journal:  Cancer Genet Cytogenet       Date:  1988-06

6.  Ring chromosomes in parosteal osteosarcoma contain sequences from 12q13-15: a combined cytogenetic and comparative genomic hybridization study.

Authors:  J Szymanska; N Mandahl; F Mertens; M Tarkkanen; E Karaharju; S Knuutila
Journal:  Genes Chromosomes Cancer       Date:  1996-05       Impact factor: 5.006

7.  A second nonrandom translocation, der(16)t(1;16)(q21;q13), in Ewing sarcoma and peripheral neuroectodermal tumor.

Authors:  E C Douglass; S T Rowe; M Valentine; D Parham; W H Meyer; E I Thompson
Journal:  Cytogenet Cell Genet       Date:  1990

8.  MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration.

Authors:  I M Ambros; P F Ambros; S Strehl; H Kovar; H Gadner; M Salzer-Kuntschik
Journal:  Cancer       Date:  1991-04-01       Impact factor: 6.860

9.  SAS amplification in soft tissue sarcomas.

Authors:  S H Smith; S W Weiss; S A Jankowski; M A Coccia; P S Meltzer
Journal:  Cancer Res       Date:  1992-07-01       Impact factor: 12.701

10.  Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma.

Authors:  C McKeon; C J Thiele; R A Ross; M Kwan; T J Triche; J S Miser; M A Israel
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

View more
  28 in total

Review 1.  Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies.

Authors:  Mandeep S Tamber; Krishan Bansal; Muh-Lii Liang; Todd G Mainprize; Bodour Salhia; Paul Northcott; Michael Taylor; James T Rutka
Journal:  Childs Nerv Syst       Date:  2006-09-02       Impact factor: 1.475

Review 2.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.

Authors:  S Knuutila; A M Björkqvist; K Autio; M Tarkkanen; M Wolf; O Monni; J Szymanska; M L Larramendy; J Tapper; H Pere; W El-Rifai; S Hemmer; V M Wasenius; V Vidgren; Y Zhu
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

3.  A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion.

Authors:  Gaëlle Pierron; Franck Tirode; Carlo Lucchesi; Stéphanie Reynaud; Stelly Ballet; Sarah Cohen-Gogo; Virginie Perrin; Jean-Michel Coindre; Olivier Delattre
Journal:  Nat Genet       Date:  2012-03-04       Impact factor: 38.330

4.  Systems Biology Analysis for Ewing Sarcoma.

Authors:  Marianyela Petrizzelli; Jane Merlevede; Andrei Zinovyev
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Recent advances in the molecular pathogenesis of Ewing's sarcoma.

Authors:  E C Toomey; J D Schiffman; S L Lessnick
Journal:  Oncogene       Date:  2010-06-14       Impact factor: 9.867

6.  Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma.

Authors:  Mona S Jahromi; Angelica R Putnam; Colleen Druzgal; Jennifer Wright; Holly Spraker-Perlman; Michelle Kinsey; Holly Zhou; Kenneth M Boucher; R Lor Randall; Kevin B Jones; David Lucas; Andrew Rosenberg; Dafydd Thomas; Stephen L Lessnick; Joshua D Schiffman
Journal:  Cancer Genet       Date:  2012 Jul-Aug

Review 7.  Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities.

Authors:  S A Burchill
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

Review 8.  Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward?

Authors:  Elizabeth R Lawlor; Poul H Sorensen
Journal:  Crit Rev Oncog       Date:  2015

9.  Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations.

Authors:  Franck Tirode; Didier Surdez; Xiaotu Ma; Matthew Parker; Marie Cécile Le Deley; Armita Bahrami; Zhaojie Zhang; Eve Lapouble; Sandrine Grossetête-Lalami; Michael Rusch; Stéphanie Reynaud; Thomas Rio-Frio; Erin Hedlund; Gang Wu; Xiang Chen; Gaelle Pierron; Odile Oberlin; Sakina Zaidi; Gordon Lemmon; Pankaj Gupta; Bhavin Vadodaria; John Easton; Marta Gut; Li Ding; Elaine R Mardis; Richard K Wilson; Sheila Shurtleff; Valérie Laurence; Jean Michon; Perrine Marec-Bérard; Ivo Gut; James Downing; Michael Dyer; Jinghui Zhang; Olivier Delattre
Journal:  Cancer Discov       Date:  2014-09-15       Impact factor: 39.397

Review 10.  Molecular pathology of sarcomas: concepts and clinical implications.

Authors:  Judith V M G Bovée; Pancras C W Hogendoorn
Journal:  Virchows Arch       Date:  2009-09-29       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.